Add to ORKGIs apixaban effective for the prevention of stroke in patients with non-valvular atrial fibrillation
WOS: 000396439000004Atrial fibrillation (AF) is a strong, independent risk factor for stroke. Until ...
The factor Xa inhibitor apixaban is one of the novel anticoagulants to emerge as alternatives to lon...
Oral anticoagulation therapy is the mainstay of stroke prevention in nonvalvular atrial fibrillation...
An evidence-based review of apixaban and its potential in the prevention of stroke in patients with ...
OBJECTIVE: The objective of this EBM review is to determine whether or not Apixaban is effective for...
The use of oral anticoagulant therapy for stroke prevention in atrial fibrillation has been transfor...
Stroke is one of the most serious cardiovascular events with severe consequences, up to paralysis an...
Adam Ioannou,1 Irene Tsappa,2 Sofia Metaxa,3 Constantinos G Missouris2,3 1Cardiology Department, Roy...
Atrial fibrillation is the most common arrhythmia in the elderly. It is responsible for significant ...
This drug information question and answer sheet discusses the use of apixaban (Eliquis) for the prim...
Atrial fibrillation is a common arrhythmia that increases the risk of stroke and systemic embolism. ...
BackgroundVitamin K antagonists are highly effective in preventing stroke in patients with atrial fi...
BACKGROUND: Atrial fibrillation (AF) is a common tachyarrhythmia in Australia, with a prevalence ove...
The articles deals with the analysis of clinical situations in patients with atrial fibrillations in...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
WOS: 000396439000004Atrial fibrillation (AF) is a strong, independent risk factor for stroke. Until ...
The factor Xa inhibitor apixaban is one of the novel anticoagulants to emerge as alternatives to lon...
Oral anticoagulation therapy is the mainstay of stroke prevention in nonvalvular atrial fibrillation...
An evidence-based review of apixaban and its potential in the prevention of stroke in patients with ...
OBJECTIVE: The objective of this EBM review is to determine whether or not Apixaban is effective for...
The use of oral anticoagulant therapy for stroke prevention in atrial fibrillation has been transfor...
Stroke is one of the most serious cardiovascular events with severe consequences, up to paralysis an...
Adam Ioannou,1 Irene Tsappa,2 Sofia Metaxa,3 Constantinos G Missouris2,3 1Cardiology Department, Roy...
Atrial fibrillation is the most common arrhythmia in the elderly. It is responsible for significant ...
This drug information question and answer sheet discusses the use of apixaban (Eliquis) for the prim...
Atrial fibrillation is a common arrhythmia that increases the risk of stroke and systemic embolism. ...
BackgroundVitamin K antagonists are highly effective in preventing stroke in patients with atrial fi...
BACKGROUND: Atrial fibrillation (AF) is a common tachyarrhythmia in Australia, with a prevalence ove...
The articles deals with the analysis of clinical situations in patients with atrial fibrillations in...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
WOS: 000396439000004Atrial fibrillation (AF) is a strong, independent risk factor for stroke. Until ...
The factor Xa inhibitor apixaban is one of the novel anticoagulants to emerge as alternatives to lon...
Oral anticoagulation therapy is the mainstay of stroke prevention in nonvalvular atrial fibrillation...